B
K. Balaskas, Leung, I., Sallo, F., Clemons, T., Bird, A. C., and Peto, T.,
“Associations Between Autofluorescence Abnormalities and Visual Acuity in Idiopathic Macular Telangiectasia Type 2: MacTel Project Report Number 5”,
Retina, vol. 34, pp. 1630-1636, 2014.
K. Balaskas, Leung, I., Sallo, F. B., Clemons, T. E., Bird, A. C., and Peto, T.,
“Associations between autofluorescence abnormalities and visual acuity in idiopathic macular telangiectasia type 2: MacTel project report number 5.”,
Retina, vol. 34, no. 8, pp. 1630-6, 2014.
S. J. Balevic, Raja, S. M., Randell, R., Deye, G. A., Conrad, T., Nakamura, A., Peyton, D. H., Shotwell, S., Liebman, K., Cohen-Wolkowiez, M., and Guptill, J. T.,
“Adverse Reactions in a Phase 1 Trial of the Anti-Malarial DM1157: An Example of Pharmacokinetic Modeling and Simulation Guiding Clinical Trial Decisions.”,
Infect Dis Ther, vol. 11, no. 2, pp. 841-852, 2022.
P. Baliga, Alvarez, S., Lindblad, A., and Zeng, L.,
“Posttransplant survival in pediatric fulminant hepatic failure: the SPLIT experience.”,
Liver Transpl, vol. 10, no. 11, pp. 1364-71, 2004.
P. Baliga, Alvarez, S., Lindblad, A., Zeng, L., and Group, T. Studies of,
“Posttransplant survival in pediatric fulminant hepatic failure: the SPLIT experience”,
Liver Transplantation, vol. 10, pp. 1364-1371, 2004.
K. Ballen, Mendizabal, A. M., Cutler, C., Politikos, I., Jamieson, K., Shpall, E. J., Dey, B. R., Attar, E., McAfee, S., Delaney, C., McCarthy, P., Ball, E. D., Kamble, R., Avigan, D., Maziarz, R. T., Ho, V. T., Koreth, J., Alyea, E., Soiffer, R., ,, Boussiotis, V., and , “Phase II Trial of Parathyroid Hormone After Double Umbilical Cord Blood Transplantation”,
Biol Blood Marrow Transplant, vol. 18, pp. 1851-1858, 2012.
K. Ballen, Mendizabal, A. M., Cutler, C., Politikos, I., Jamieson, K., Shpall, E. J., Dey, B. R., Attar, E., McAfee, S., Delaney, C., McCarthy, P., Ball, E. D., Kamble, R., Avigan, D., Maziarz, R. T., Ho, V. T., Koreth, J., Alyea, E., Soiffer, R., Wingard, J. R., Boussiotis, V., Spitzer, T. R., and Antin, J. H.,
“Phase II trial of parathyroid hormone after double umbilical cord blood transplantation.”,
Biol Blood Marrow Transplant, vol. 18, no. 12, pp. 1851-8, 2012.
J. C. Baranda, Diaz, F. J., Rubinstein, L., Shields, A. F., Dayyani, F., Mehta, A., Mehnert, J. M., Trent, J., Mabaera, R., Mooney, M., Moscow, J. A., Doroshow, J., Waters, B., Ivy, P., Gore, S. D., and Thomas, A.,
“Expanding access to early phase trials: the CATCH-UP.2020 experience.”,
JNCI Cancer Spectr, vol. 7, no. 1, 2023.
A. Barasch, Cunha-Cruz, J., Curro, F. A., Hujoel, P., Sung, A. H., Vena, D., Voinea-Griffin, A. E., Beadnell, S., Craig, R. G., DeRouen, T., Desaranayake, A., Gilbert, A., Gilbert, G. H., Goldberg, K., Hauley, R., Hashimoto, M., Holmes, J., Latzke, B., Leroux, B., Lindblad, A., Richman, J., Safford, M., Ship, J., Thompson, V. P., O Williams, D., and Yin, W.,
“Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRN.”,
J Dent Res, vol. 90, no. 4, pp. 439-44, 2011.
A. Barasch, Cunha-Cruz, J., Curro, F., Hujoel, P., Sung, A., Vena, D., Voinea-Griffin, A., Beadnell, S., Craig, R., DeRouen, T., Desaranayake, A., Gilbert, A., Gilbert, G., Goldberg, K., Hauley, R., Hashimoto, M., Holmes, J., Latzke, B., Leroux, B., Lindblad, A., and Richman, J.,
“Risk Factors for Osteonecrosis of the Jaws: A Case-Control Study from the CONDOR Dental PBRN”,
J Dent Res, vol. 90, pp. 439-444, 2011.
C. E. H. Barber, Marshall, D. A., Szefer, E., Barnabe, C., Shiff, N. J., Bykerk, V., Homik, J., J Thorne, C., Ahluwalia, V., Benseler, S., Mosher, D., Twilt, M., and Lacaille, D.,
“A population-based approach to reporting system-level performance measures for rheumatoid arthritis care.”,
Arthritis Care Res (Hoboken), 2020.
D. Barouch, Liu, J., H, L., Maxfield, L. F., Abbink, P., Lynch, D. M., Iampietro, M., San Miguel, A., Seaman, M. S., Ferrari, G., D, F., Ourmanov, I., Hirsch, V. M., Carville, A., Mansfield, K., Stablein, D., Pau, M., Schuitemaker, H., Sadoff, J. C., Billings, E. M., and Rao, M.,
“Vaccine Protection Against Acquisition of Neutralization-Resistant SIV Challenges in Rhesus Monkeys”,
Nature, vol. 482, pp. 89-93, 2012.
D. H. Barouch, Liu, J., Li, H., Maxfield, L. F., Abbink, P., Lynch, D. M., M Iampietro, J., SanMiguel, A., Seaman, M. S., Ferrari, G., Forthal, D. N., Ourmanov, I., Hirsch, V. M., Carville, A., Mansfield, K. G., Stablein, D., Pau, M. G., Schuitemaker, H., Sadoff, J. C., Billings, E. A., Rao, M., Robb, M. L., Kim, J. H., Marovich, M. A., Goudsmit, J., and Michael, N. L.,
“Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys.”,
Nature, vol. 482, no. 7383, pp. 89-93, 2012.
G. B. Bart, Saxon, A., Fiellin, D. A., McNeely, J., Muench, J. P., Shanahan, C. W., Huntley, K., and Gore-Langton, R. E.,
“Developing a clinical decision support for opioid use disorders: a NIDA center for the clinical trials network working group report.”,
Addict Sci Clin Pract, vol. 15, no. 1, p. 4, 2020.
F. B. Barton, Rickels, M. R., Alejandro, R., Hering, B. J., Wease, S., Naziruddin, B., Oberholzer, J., Odorico, J. S., Garfinkel, M. R., Levy, M., Pattou, F., Berney, T., Secchi, A., Messinger, S., Senior, P. A., Maffi, P., Posselt, A., Stock, P. G., Kaufman, D. B., Luo, X., Kandeel, F., Cagliero, E., Turgeon, N. A., Witkowski, P., Naji, A., O'Connell, P. J., Greenbaum, C., Kudva, Y. C., Brayman, K. L., Aull, M. J., Larsen, C., Kay, T. W. H., Fernandez, L. A., Vantyghem, M. - C., Bellin, M., and Shapiro, A. M. James,
“Improvement in outcomes of clinical islet transplantation: 1999-2010.”,
Diabetes Care, vol. 35, no. 7, pp. 1436-45, 2012.
Q. Bashir, Nishihori, T., Pasquini, M. C., Martens, M. J., Wu, J., Alsina, M., Anasetti, C., Brunstein, C., Dawson, P., Efebera, Y., Gasparetto, C., Geller, N., Giralt, S., Hall, A. C., Koreth, J., McCarthy, P., Scott, E., Stadtmauer, E. A., Vesole, D. H., and Hari, P.,
“A Multicenter Phase II, Double-Blind, Placebo-Controlled Trial of Maintenance Ixazomib After Allogeneic Transplantation for High-Risk Multiple Myeloma: Results of the Blood and Marrow Transplant Clinical Trials Network 1302 Trial”,
Transplant Cell Ther, vol. S2666-6367, no. 22, pp. 01467-1, 2022.
M. A. Baum, Stablein, D., Panzarino, V. M., Tejani, A., and Harmon, W.,
“Graft loss due to recurrence eliminates the graft survival advantage of living donor (LD) over Cadaveric (CD) renal transplants (Tx) in children with focal segmental glomerulosclerosis (FSGS): A report of the North American Pediatric Transplant Cooperati”, 1999.
M. A. Baum, Stablein, D. M., Panzaarino, V. M., Tejani, A., Harmon, W. E., and , “Loss of living donor renal allograft survival advantage in children with focal segmental glomerulosclerosis”,
Kidney Int., vol. 59, pp. 328-33, 2001.
M. A. Baum, Stablein, D. M., Panzarino, V. M., Tejani, A., Harmon, W. E., and Alexander, S. R.,
“Loss of living donor renal allograft survival advantage in children with focal segmental glomerulosclerosis.”,
Kidney Int, vol. 59, no. 1, pp. 328-33, 2001.
M. A. Baum, Ho, M., Stablein, D., and , “North American Pediatric Renal Transplant Cooperative Study. Outcome of renal transplantation in adolescents with focal segmental glomerulosclerosis”,
Pediatr Transplantation, vol. 6, pp. 488-92, 2002.
M. A. Baum, Ho, M., Stablein, D., and Alexander, S. R.,
“Outcome of renal transplantation in adolescents with focal segmental glomerulosclerosis.”,
Pediatr Transplant, vol. 6, no. 6, pp. 488-92, 2002.
L. A. Baxter-Lowe, Kim, Y., Carter, S., Fernandez-Vina, M., Wagner, E., Jensen, L., Fraser, J., Kernan, N., and Kurtzberg, J.,
“Ability of minority patients to find donors from an ethnically diverse cord blood bank”, 2002.
]